Recent Quotes
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

17.53 +0.04 (+0.23%)
Official Closing Price Updated: 4:10 PM EDT, Apr 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,969,594
Open 17.43
Bid (Size) 17.48 (500)
Ask (Size) 17.53 (300)
Prev. Close 17.49
Today's Range 17.39 - 17.66
52wk Range 14.02 - 25.17
Shares Outstanding N/A
Dividend Yield 4.75%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Want Reliable Dividend Income? These 3 Stocks Yield 5% and Have Been Raising Their Payouts for Decades ↗
Via The Motley Fool
News headline image
Billionaire Investor Cuts Tylenol Maker Kenvue Stake By 64% ↗
Daniel Loeb trims major stake in Kenvue as company advances restructuring and prepares for acquisition by Kimberly-Clark. 
Via Benzinga

Performance

YTD
+1.2%
+1.2%
1 Month
+0.1%
+0.1%
3 Month
-0.6%
-0.6%
6 Month
+16.2%
+16.2%
1 Year
-24.1%
-24.1%

More News

Read More
News headline image
Kenvue to Announce First Quarter 2026 Results on May 7, 2026
From Kenvue
Via Business Wire
News headline image
Here's What to Expect From Kenvue's Next Earnings Report
Via Barchart.com
Topics ETFs
News headline image
The Smartest Dividend Stocks to Buy With $2,000 Right Now ↗
Via The Motley Fool
News headline image
Meet the Dividend King That Just Raised Its Payout For the 70th Consecutive Year. Here's Why It's a No-Brainer Buy Before the End of April. ↗
Via The Motley Fool
Topics Economy
News headline image
3 Healthcare Stocks That Have Held Up in Every Market Downturn ↗
Via The Motley Fool
Topics Economy
News headline image
Skip the 10-Year Bond? 3 Dividend Aristocrats to Consider Now ↗
Via MarketBeat
Topics Bonds Earnings Economy
News headline image
J&J Shatters Estimates as Oncology and MedTech Power 2026 Outlook Higher
Via MarketMinute
Topics Economy Intellectual Property
News headline image
This Value Stock Yields 5.3% and Has Paid a Dividend for 92 Consecutive Years. Here's Why It's a Buy in April. ↗
Via The Motley Fool
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone
Via MarketMinute
Topics Economy Intellectual Property
News headline image
The New J&J: A 2026 Deep Dive into the Global Healthcare Titan
Via Finterra
Topics Artificial Intelligence Death Economy
News headline image
Better Buy Right Now: Johnson & Johnson Vs. Pfizer ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
4 Stocks That Can Fund Decades of Passive Income -- Buy Them While They're Down ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Wall Street's Great Rotation: Goldman and JPMorgan Pivot to 'Innovation Supercycle' as Interest Income Peaks
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Could Buying This Dividend Pharma Stock Today Set You Up for Life? ↗
Via The Motley Fool
Topics Stocks
News headline image
The Great Consolidation: Q1 2026 M&A Activity Shatters Records Amid $3 Trillion Private Equity Surge
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
Looks Like M&A Week in 3 Different Sectors ↗
Via The Motley Fool
News headline image
These 3 Beaten-Down Stocks Haven't Been This Cheap in Over a Decade ↗
Via The Motley Fool
Topics Economy World Trade
News headline image
Wall Street's Advisory Windfall: Goldman Sachs and JPMorgan Lead the M&A Renaissance
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
This Healthcare Stock Barely Flinches During Market Sell-Offs ↗
Via The Motley Fool
Topics Economy Stocks
News headline image
The New Blue-Chip: How Johnson & Johnson Refined Its Empire for a High-Growth Future
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
The Great Divergence: Q1 2026 M&A Hits Record $813.3 Billion Amidst "K-Shaped" Recovery
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Breathing Easy: Prestige Consumer Healthcare Inks $1.045 Billion Deal to Acquire Breathe Right and Expansion Portfolio
Via MarketMinute
Topics Economy

Frequently Asked Questions

Is Kenvue Inc. Common Stock publicly traded?
Yes, Kenvue Inc. Common Stock is publicly traded.
What exchange does Kenvue Inc. Common Stock trade on?
Kenvue Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Kenvue Inc. Common Stock?
The ticker symbol for Kenvue Inc. Common Stock is KVUE on the New York Stock Exchange
What is the current price of Kenvue Inc. Common Stock?
The current price of Kenvue Inc. Common Stock is 17.53
When was Kenvue Inc. Common Stock last traded?
The last trade of Kenvue Inc. Common Stock was at 04/27/26 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>